SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950136-07-005073
Filing Date
2007-07-24
Accepted
2007-07-24 10:37:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 file1.htm S-3 264094
2 OPINION OF MORRISON & FOERSTER LLP file2.htm EX-5.1 10787
3 CONSENT OF KESSELMAN & KESSELMAN file3.htm EX-23.2 2668
4 ebox.gif GRAPHIC 58
5 spacer.gif GRAPHIC 43
6 cbox.gif GRAPHIC 61
7 html_protalixlogo.jpg GRAPHIC 19177
  Complete submission text file 0000950136-07-005073.txt   306307
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-144801 | Film No.: 07995218
SIC: 2836 Biological Products, (No Diagnostic Substances)